Philadelphia has filed a lawsuit against CVS Health, Express Scripts, Optum, and other pharmacy benefit managers, alleging that they recklessly contributed to the city's devastating opioid crisis. The city claims that these companies knowingly over-prescribed opioids, misleadingly marketed them as a way to boost profits, and prioritized financial gain over public health.
The lawsuit says that as middlemen between insurers, manufacturers, and pharmacies, CVS Health, Express Scripts, Optum, and others had access to vast amounts of data on opioid distribution, insurance claims, and clinical records. Despite this knowledge, they allegedly continued to prescribe and dispense opioids in exchange for rebates and fees from pharmaceutical companies.
The city is seeking damages, as well as corrective action programs to address the crisis. Fatal overdoses peaked at 1,400 in Philadelphia in 2022, with nearly all of them involving opioids. The opioid epidemic has disproportionately affected Black and Hispanic communities.
In contrast, CVS Health has denied the allegations, stating that they are "without merit" and intend to defend themselves vigorously. Express Scripts and Optum have not commented on the matter yet.
The lawsuit comes as Philadelphia is seeking to address the impact of its opioid crisis, which has led to a significant increase in municipal services costs and public health concerns. The city's chief public safety director says that holding those responsible for exacerbating the crisis will help right this "tragic wrong" and mitigate the effects on communities like Kensington.
The lawsuit says that as middlemen between insurers, manufacturers, and pharmacies, CVS Health, Express Scripts, Optum, and others had access to vast amounts of data on opioid distribution, insurance claims, and clinical records. Despite this knowledge, they allegedly continued to prescribe and dispense opioids in exchange for rebates and fees from pharmaceutical companies.
The city is seeking damages, as well as corrective action programs to address the crisis. Fatal overdoses peaked at 1,400 in Philadelphia in 2022, with nearly all of them involving opioids. The opioid epidemic has disproportionately affected Black and Hispanic communities.
In contrast, CVS Health has denied the allegations, stating that they are "without merit" and intend to defend themselves vigorously. Express Scripts and Optum have not commented on the matter yet.
The lawsuit comes as Philadelphia is seeking to address the impact of its opioid crisis, which has led to a significant increase in municipal services costs and public health concerns. The city's chief public safety director says that holding those responsible for exacerbating the crisis will help right this "tragic wrong" and mitigate the effects on communities like Kensington.